Create stable, long-term investment portfolio with strong, consistent stocks.
Start Research-backed Investing ...Now.
Worth Seeing!
Invest in Cases Systematically - Every stock is handpicked
Start Buying Now
Start Buying Now
BSE: 523333 | NSE: | Rubber Products | Small Cap
Data is not available for this company.
No data found
No data found
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 3.1% | 7.3% | 0.4% | -10.7% | -6.2% | 3% | -110.2% | -38.7% | -19.4% | -42.8% | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||||||||||
| Sales ⓘ | 49.1 | 43.3 | 35.2 | 46 | 18.9 | 25.9 | 0.3 | 0 | 10.9 | 16.2 | 9 |
| Sales YoY Gr. | - | -11.8% | -18.8% | 30.9% | -59% | 37% | -99% | -88.5% | 36,266.7% | 48.5% | - |
| Adj EPS ⓘ | 0 | 0.1 | -4.4 | -6.8 | -5.3 | -1.8 | -30.5 | -13.1 | -11 | -15.4 | -16.6 |
| YoY Gr. | - | 550% | -3507.7% | NA | NA | NA | NA | NA | NA | NA | - |
| BVPS (₹) ⓘ | 6.2 | 6.6 | 2.6 | 9.1 | 2.9 | 0.8 | -54.6 | -67.7 | -78.7 | -94.1 | -103.6 |
| Adj Net Profit ⓘ | 0 | 0.2 | -5.3 | -8.3 | -6.5 | -2.3 | -37.4 | -16.1 | -13.5 | -18.9 | -20 |
| Cash Flow from Ops. ⓘ | 3.6 | -0.4 | 3.8 | 20.5 | -6.4 | 6.1 | -40.5 | 2.4 | -0.9 | 0.7 | - |
| Debt/CF from Ops. ⓘ | 14.6 | -138.2 | 14.8 | 1.9 | -7 | 6.8 | -2.1 | 43 | -128 | 194.4 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -11.6% | -3% | 296.4% | 48.5% | ||||
| Adj EPS ⓘ | -309.3% | NA | NA | NA | ||||
| BVPSⓘ | -235.2% | -300.8% | NA | NA | ||||
| Share Price | - | - | - | - | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0.2 | 1.4 | -67 | -92.3 | -74.1 | -64.2 | 117.8 | 21.8 | 15.3 | 18.1 | 16.8 |
| Op. Profit Mgn % ⓘ | 6 | 14.9 | 10.5 | -13.7 | -21.3 | 1 | -4123.7 | -7462.1 | 17.6 | -12.5 | -20.2 |
| Net Profit Mgn % ⓘ | 0.1 | 0.4 | -15.1 | -18.1 | -34.5 | -8.7 | -14530.6 | -58751.4 | -123.7 | -116.7 | -217.1 |
| Debt to Equity ⓘ | 6.1 | 5.9 | 12.8 | 3.2 | 9.4 | 18.6 | -1.3 | -1.3 | -1.2 | -1.2 | - |
| Working Cap Days ⓘ | 215 | 248 | 295 | 230 | 552 | 281 | 14,043 | 67,295 | 223 | 134 | 23 |
| Cash Conv. Cycle ⓘ | 130 | 156 | 203 | 174 | 445 | 210 | 7,468 | 7,812 | 4 | 24 | -546 |
No data to display
Return on Equity has declined versus last 3 years average to %
Sales growth has been subdued in last 3 years %
Sales growth is not so good in last 4 quarters at %
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | -16.6 | -11 |
| TTM Sales (₹ Cr.) | 9.4 | 10.9 |
| BVPS (₹.) ⓘ | -103.6 | -78.9 |
| Reserves (₹ Cr.) ⓘ | -139 | -109 |
| P/BV ⓘ | -0.01 | -0.01 |
| PE ⓘ | 0.00 | 0.00 |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 0.82 / 0.82 |
| All Time Low / High (₹) | 0.79 / 80.00 |
| Market Cap (₹ Cr.) | 1 |
| Equity (₹ Cr.) | 12.3 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 34.5 |
| Pledged * | 93.93 | 93.93 | 93.93 | 93.93 | 93.93 | 93.93 | 93.93 | 93.93 | 93.93 | 93.93 |
| PARTICULARS | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 49.10 | 43.29 | 35.17 | 46.02 | 18.87 | 25.85 | 0.26 | 0.03 | 10.91 | 16.20 |
| Operating Expenses ⓘ | 46.18 | 37.30 | 31.58 | 52.81 | 23.20 | 26.10 | 11.24 | 2.11 | 8.99 | 18.23 |
| Manufacturing Costs | 5.72 | 4.28 | 4.02 | 10.83 | 3.88 | 2.85 | 0.36 | 0.05 | 2.64 | 3.16 |
| Material Costs | 26.57 | 19.51 | 18.59 | 27.33 | 10.12 | 15.38 | 2.28 | 0.04 | 3.52 | 8.38 |
| Employee Cost | 4.27 | 4.49 | 4.73 | 6.07 | 5.32 | 4.89 | 2.95 | 0.25 | 1.68 | 3.76 |
| Other Costs ⓘ | 9.62 | 9.02 | 4.24 | 8.57 | 3.88 | 2.98 | 5.65 | 1.77 | 1.15 | 2.93 |
| Operating Profit ⓘ | 2.92 | 5.99 | 3.59 | -6.80 | -4.33 | -0.25 | -10.98 | -2.08 | 1.92 | -2.03 |
| Operating Profit Margin (%) | 5.9% | 13.8% | 10.2% | -14.8% | -23.0% | -1.0% | -4,269.7% | -7,622.6% | 17.6% | -12.5% |
| Other Income ⓘ | 2.64 | 1.99 | 0.92 | 2.69 | 1.76 | 0.86 | 1.89 | 0.12 | 0.15 | 0.21 |
| Interest ⓘ | 2.73 | 6.44 | 7.90 | 3.20 | 4.76 | 5.24 | 3.87 | 11.85 | 13.33 | 14.85 |
| Depreciation ⓘ | 1.93 | 1.96 | 2.66 | 2.73 | 2.74 | 2.40 | 2.33 | 2.28 | 2.23 | 2.25 |
| Exceptional Items ⓘ | 0 | 0 | 0 | 21.65 | -3.49 | 0 | -44 | 0 | -0.04 | 0.02 |
| Profit Before Tax ⓘ | 0.89 | -0.42 | -6.06 | 11.61 | -13.57 | -7.04 | -59.29 | -16.10 | -13.53 | -18.90 |
| Tax ⓘ | 0.85 | -0.26 | -0.70 | 5.12 | -4.52 | -4.47 | 8.64 | 0 | 0 | 0 |
| Profit After Tax | 0.04 | -0.16 | -5.36 | 6.48 | -9.05 | -2.57 | -67.93 | -16.10 | -13.53 | -18.90 |
| PAT Margin (%) | 0.1% | -0.4% | -15.2% | 14.1% | -47.9% | -9.9% | -26,418.2% | -58,863.7% | -124.0% | -116.0% |
| Adjusted EPS (₹) | 0.0 | -0.1 | -4.5 | 5.3 | -7.4 | -2.1 | -55.4 | -13.1 | -11.0 | -15.4 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 |
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 10.76 | 10.60 | 5.24 | 12.77 | 4.78 | 2.24 | -65.69 | -81.79 | -95.32 | -114.22 |
| Share Capital ⓘ | 13.22 | 13.22 | 13.22 | 13.52 | 13.52 | 13.52 | 13.52 | 13.52 | 13.52 | 13.52 |
| Reserves ⓘ | -2.46 | -2.62 | -7.98 | -0.75 | -8.74 | -11.28 | -79.21 | -95.31 | -108.84 | -127.74 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt | 52.69 | 54.58 | 55.69 | 39.58 | 44.91 | 41.68 | 84.68 | 102.99 | 117.17 | 132.16 |
| Long Term Debt | 52.69 | 54.58 | 55.69 | 39.58 | 44.91 | 41.68 | 84.68 | 102.99 | 0.02 | 0 |
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 117.15 | 132.16 |
| Trade Payables | 7.79 | 7.45 | 4.83 | 7.16 | 1.46 | 0.85 | 0.85 | 2.26 | 3.34 | 1.56 |
| Others Liabilities ⓘ | -1.79 | -2.30 | -2.48 | 8.73 | 6.33 | 0.04 | 12.35 | 5.32 | 5.73 | 4.32 |
| Total Liabilities ⓘ | 69.45 | 70.33 | 63.27 | 68.24 | 57.48 | 44.81 | 32.18 | 28.78 | 30.92 | 23.82 |
Fixed Assets | ||||||||||
| Gross Block | 38.15 | 52.04 | 52.32 | 54.03 | 53.83 | 53.64 | 52.11 | 51.95 | 51.99 | 51.97 |
| Accumulated Depreciation | 13.03 | 14.99 | 17.50 | 20.17 | 22.73 | 24.78 | 25.97 | 28.15 | 30.37 | 32.57 |
| Net Fixed Assetsⓘ | 25.12 | 37.05 | 34.82 | 33.86 | 31.10 | 28.86 | 26.13 | 23.80 | 21.61 | 19.40 |
| CWIP ⓘ | 10.34 | 0.01 | 0.27 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investmentsⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventories | 15.99 | 20.64 | 14.83 | 17.04 | 12.71 | 3.49 | 0.69 | 0.46 | 3.52 | 1.48 |
| Trade Receivables | 9.65 | 7.36 | 10.36 | 12.56 | 9.84 | 6.38 | 0.03 | 0.03 | 1.75 | 0.16 |
| Cash Equivalents | 3.68 | 1.41 | 0.88 | 2.46 | 0.81 | 1.73 | 0.48 | 0.46 | 0.50 | 1.35 |
| Others Assetsⓘ | 4.67 | 3.86 | 2.12 | 2.29 | 3.02 | 4.35 | 4.86 | 4.03 | 3.53 | 1.44 |
| Total Assets ⓘ | 69.45 | 70.33 | 63.27 | 68.24 | 57.48 | 44.81 | 32.18 | 28.78 | 30.92 | 23.82 |
| PARTICULARS | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | 3.62 | -0.40 | 3.77 | 20.50 | -6.41 | 6.12 | -40.49 | 2.39 | -0.92 | 0.68 |
| PBT ⓘ | 0.89 | -0.42 | -6.06 | -10.04 | -10.08 | -7.04 | -15.29 | -16.10 | -13.53 | -18.90 |
| Adjustment ⓘ | 4.88 | 8.69 | 10.64 | 5.53 | 6 | 6.67 | 5.34 | 14.55 | 15.33 | 18.25 |
| Changes in Working Capital ⓘ | 0.54 | -2.84 | 1.91 | 3.81 | 1.09 | 6.55 | 13.83 | 3.94 | -2.71 | 1.34 |
| Tax Paid ⓘ | 0 | 0 | 0 | -0.45 | 0.07 | -0.06 | -0.38 | 0 | 0 | -0.01 |
| Cash Flow From Investing Activity ⓘ | -4.40 | -3.57 | -0.73 | -1.21 | 0.97 | 0.62 | 0.38 | 0.01 | -0.05 | 0.05 |
| Capex | -2.76 | -3.57 | -0.73 | -1.71 | 0.22 | -0.09 | 0.08 | 0.01 | -0.05 | -0.04 |
| Net Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others ⓘ | -1.65 | 0 | 0 | 0.50 | 0.75 | 0.71 | 0.30 | 0 | 0 | 0.09 |
| Cash Flow From Financing Activityⓘ | 2.97 | 1.62 | -3.58 | -17.71 | 3.89 | -5.78 | 39.14 | -2.42 | 0.98 | 0.18 |
| Net Proceeds from Shares ⓘ | 0.86 | 0 | 0 | 1.05 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Proceeds from Borrowing ⓘ | 0 | 0 | 0 | 0 | 3.94 | -5.51 | 0 | 0 | 0 | 0 |
| Interest Paid ⓘ | 0 | 0 | 0 | -8.07 | -1.10 | -0.27 | -3.86 | -11.84 | -13.21 | -14.81 |
| Dividend Paid ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others ⓘ | 2.11 | 1.62 | -3.58 | -10.69 | 1.05 | 0 | 42.99 | 9.42 | 14.19 | 14.99 |
| Net Cash Flow ⓘ | 2.18 | -2.35 | -0.53 | 1.58 | -1.55 | 0.96 | -0.98 | -0.02 | 0.02 | 0.92 |
| PARTICULARS | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 0.53 | -2.08 | -97.02 | 91.16 | -123.55 | -113.6 | N/A | N/A | N/A | N/A |
| ROCE (%) | 5.98 | 9.62 | 2.98 | 26.45 | -17.33 | -3.84 | N/A | N/A | N/A | N/A |
| Asset Turnover Ratio | 0.72 | 0.62 | 0.53 | 0.7 | 0.3 | 0.51 | 0.01 | 0 | 0.37 | 0.59 |
| PAT to CFO Conversion(x) | 90.5 | N/A | N/A | 3.16 | N/A | N/A | N/A | N/A | N/A | N/A | Working Capital Days |
| Receivable Days | 91 | 72 | 92 | 91 | 217 | 114 | 4,544 | 351 | 30 | 22 |
| Inventory Days | 103 | 154 | 184 | 126 | 288 | 114 | 2,964 | 7,634 | 67 | 56 |
| Payable Days | 110 | 143 | 121 | 80 | 155 | 27 | 136 | 0 | 291 | 107 |
Polar Pharma India, earlier known as ‘Palar Latex Ltd, was launched in the year 1988 and starterd the commercial production from its Balasore plant in 1991.
The company is committed to better, safer, more enjoyable life for the people. A company where people and technology continuously work hand in hand to evolve new standards of excellence in the field of male prophylactics. Where business values are re-defined with greater, global social concerns in mind. And the concern is turned into an action point in the company’s mission statement itself.
Today, Polar Pharma enjoys worldwide popularity and trust, as the key producer of high quality, male latex prophylactics in India. In fact, the company is one of the largest private sector condom manufacturing units in Asia, with an installed capacity of over 700 million pieces per annum.
A qualified team of professionals conduct regular checks for every batch produced to ensure consistency and quality of the finished products. PPIL has an in-house fully equipped product testing laboratory for quality checks
Product range of the company includes:
Contraceptives – condoms of the following types:
Achievements/ recognition :
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
